The Egg Factor

In this episode of The Egg Factor, Dr. Norbert Gleicher and Dr. David Barad sit down to discuss the topic of Natural Cycle IVF vs Stimulated Cycles. Learn how each approach works, who may benefit from each option, and the key factors to consider when choosing a treatment path. Whether you're beginning your fertility journey or looking to better understand your options, this episode offers clear, expert insights to help you make informed decisions.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode, Dr. Norbert Gleicher discusses what has been learned from transferring embryos identified as chromosomally abnormal during IVF treatment. He explores how these cases have challenged assumptions about embryo selection, implantation potential, and the role of genetic testing in fertility care, providing important insights for patients and clinicians navigating IVF decisions.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this video, Dr. Norbert Gleicher discusses how low testosterone can affect ovarian function, egg development, and reproductive health in women. He explains why balanced hormone levels are important for fertility and how testosterone may be considered as part of an individualized approach to fertility care in selected patients. 

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher explores the science of ovarian aging and what it means for fertility. He discusses why ovarian reserve declines, how age affects egg quality, and emerging research that could change the way we understand reproductive aging.

Whether you're trying to conceive, considering fertility preservation, or simply interested in the latest advances in reproductive medicine, this episode offers practical insights into one of fertility's most important topics.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. David Barad explores the CHR's Second Opinion Program and how it helps patients gain a fresh perspective on their fertility care. Learn what the program includes, who can benefit from a second opinion, and how expert review of your medical history and treatment plan may uncover new options and opportunities.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher explores the complex and relationship between autoimmunity and implantation failure.

Drawing on decades of clinical experience and research, Dr. Gleicher discusses how autoimmune conditions may influence endometrial receptivity, embryo implantation, and pregnancy outcomes. He examines the latest scientific evidence, addresses common misconceptions, and shares his perspective on which patients may benefit from immune-related testing and treatment.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. David Barad explains how fertility specialists tailor IVF protocols for patients with diminished ovarian reserve, discussing ovarian response, medication strategies, egg quality versus egg quantity, and what patients can realistically expect. Tune in for an evidence-based conversation that helps demystify one of the most common and challenging fertility diagnoses.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, our very own Dr. Norbert Gleicher and Dr. David Barad are joined by Lab Director Emanuela Molinari to discuss IVM and Early Retrieval. Tune into this episode to learn how retrieving immature eggs earlier in the cycle and maturing them in the lab can offer an alternative to traditional IVF, with potential benefits for certain patients. 

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

Planning summer travel while undergoing IVF? In this video, Dr. Sonia Gayete-Lafuente explores how travel can impact IVF treatment, including medication schedules, monitoring appointments, stress levels, and overall treatment success. Learn practical tips for traveling safely during IVF and how to coordinate your plans with your fertility clinic.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Sonia Gayete-Lafuente is joined by Lab Director Emanuela Molinari to discuss why fertility professionals should attend the Foundation for Reproductive Medicine Conference (FRMC) 2026. FRMC 2026 is a premier international gathering focused on independent, patient-centered research and innovation in reproductive medicine, taking place on December 4-6 at the Metropolitan Club in New York. Organized by the Foundation for Reproductive Medicine, it brings together physicians, scientists, and allied professionals to critically reassess fertility care and explore emerging evidence.

If you're interested in purchasing tickets, please visit the link here: https://whova.com/portal/registration/GM2LL8NP2n7gCLCnO9y-/

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com 

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork